Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024;36(3):222-228.
doi: 10.5455/msm.2024.36.222-228.

Seroprevalence of SARS-COV-2 Antibodies Associated with the Use of Personal Protective Equipment in Healthcare Workers

Affiliations

Seroprevalence of SARS-COV-2 Antibodies Associated with the Use of Personal Protective Equipment in Healthcare Workers

Amela Dubinovic-Rekic et al. Mater Sociomed. 2024.

Abstract

Background: Hypothetically, PPE played an estimated influential role in preventing SARS-CoV-2 transmission among HCWs before immune-prophylaxis by vaccination in BH. Objective: This research aims to determine the relationship between PPE use and the serological response to SARS-COV-2 among HCWs.

Methods: The sample contained 127 COVID-19 outpatients with an average age of 43.5 ± 10.8, 66% women, and 80 (63%) health workers as the study group (37% non-medical workers as a control subjects). The created questionnaire collected sociodemographic data on comorbidity or not, application of PPE, and severity of the clinical picture of COVID-19 infection.

Results: All subjects were monitored for the dynamics of antibodies, separately for IgM- and Ig-G three times, repeated every 3 months (only three before immuno-prophylaxis by vaccinations). A serological investigation of subjects' blood was collected by trained medical staff in vacutainers with a clotting activator to obtain the subjects' serum centrifuged, separated, and tested on the AFIAS 6 COVID-19 apparatus. Healthcare workers who did not wear goggles had significantly higher IgM antibody levels than HCWs who use them [F=9.359 (1, 102), p=.003, partial η2=.084]. Also, HCWs who did not use a visor had significantly higher IgM nucleocapsid antibody titer than those who used it daily or occasionally [F=4.790 (1, 102), p=.031, partial η2=.045]. Increase SARAS-COV-2 IgM titer three, six, or nine months after past COVID-19 infection and before vaccination.

Conclusion: It presents a new acute or recent asymptomatic infection in our HCWs and unrecognized COVID-19. This implies considerable source and unrecognized risk of transmission of the SARS-COV-2 virus, and among HCWs, COVID-19 is an infectious disease with a high prevalence rate.

Keywords: COVID-19; IgM and IgG; SARS-COV-2; healthcare workers; seroprevalence.

PubMed Disclaimer

Conflict of interest statement

None to declare.

Figures

Figure 1.
Figure 1.. Profile of IgM antibody values based on the use of personal protective equipment (PPE) through five measurments. The X-axis shows the number of measurments at which the antibody value was determined. The Y-axis shows the value of antibodies in COI units. The frequency of using PPE is represented by the responses: every day, never and sometimes.
Figure 2.
Figure 2.. Profile of IgG antibody values based on the use of personal protective equipment (PPE) through five measurments. The X-axis shows the number of measurments at which the antibody value was determined. The Y-axis shows the value of antibodies in COI units. The frequency of using PPE is represented by the responses: every day, never and sometimes.

Similar articles

References

    1. Huang Y, Yang L, Dai M, Tian F, Chen K. Epidemic situation and forecasting of COVID-19 in and outside China. J Infect. Bull World Health Organ. 2020 (E-pub ahead of print)
    1. Tang JW, Tambyah PA, Hui DSC. Emergence of a novel coronavirus causing respiratory illness from Wuhan, China. J Infect. 2020;80(3):350–371. - PMC - PubMed
    1. European Centre for Disease Prevention and Control. Download historical data (to 14 December 2020) on the daily number of new reported COVID-19 cases and deaths worldwide. ECDC. 2020. https://opendata.ecdc.europa.eu/covid19/case distribution/csv.
    1. Nicoll A, Rrias VLC. Van-Tam J, editor. National and international public health measures. Pandemic Influence. CABI Digital Library. 2012:152–163.
    1. Ponjavić M, Karabegović A, Ferhatbegović E, Tahirović E, Uzunović S, Travar M, et al. Spatial-temporal data visualization for monitoring of control measures in the prevention of the spread of COVID-19 in Bosnia and Herzegovina. Med Glas (Zenica) 2020;17(2):265–274. - PubMed

LinkOut - more resources